Ling Lu, MD, PhD

Prof. Lu is the Vice President of Xuzhou Medical University and the Party Secretary of the Affiliated Hospital of Xuzhou Medical University. He conducts basic and translational research on liver transplantation and transplant immunology. Prof. Lu was the first to apply regulatory T cells to induce immune tolerance in patients after liver transplantation internationally.

Prof. Lu has published over one hundred papers in journals such as Nat Rev Immunol, Cancer Discov, Gut, J Hepatol, and Hepatology. He has achieved an H-index of 45, and four of his original articles have been selected as ESI Highly Cited Papers. He has been continuously recognized as one of the Most Cited Chinese Researchers from 2014 to 2023.